Corbus Pharmaceuticals (CRBP) EPS (2014 - 2026)
Corbus Pharmaceuticals (CRBP) EPS from Sep 30, 2014 to Mar 31, 2026. The TTM Corbus Pharmaceuticals (CRBP) EPS is -$5.76. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Corbus Pharmaceuticals (CRBP) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +38.19% |
| 3 Years TTM | -21.89% |
| 5 Years TTM | -28.48% |
| 10 Years TTM | -3.92% |
| All Time TTM | -2.52% |
Annual EPS change of Corbus Pharmaceuticals (CRBP)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.29 | -70.96% |
| 2025 | -$4.46 | +35.08% |
| 2024 | -$3.30 | -67.25% |
| 2023 | -$10.08 | -0.70% |
| 2022 | -$10.15 | -7.25% |
| 2021 | -$10.95 | -67.62% |
| 2020 | -$33.80 | +1.88% |
| 2019 | -$33.18 | +13.61% |
| 2018 | -$29.20 | +66.78% |
| 2017 | -$17.51 | +30.26% |
| 2016 | -$13.44 | +90.20% |
| 2015 | -$7.07 | +140.33% |
| 2014 | -$2.94 | N/A |
Comparison Corbus Pharmaceuticals (CRBP) five years EPS CAGR with competitors
Corbus Pharmaceuticals (CRBP) five years EPS CAGR is -33.12%.